1 MAGNETIC RESONANCE DEVICE FIELD OF THE INVENTION The present invention relates to nuclear magnetic resonance devices, apparatuses, equipments or systems and more precisely to nuclear magnetic resonance devices, apparatuses, equipments or systems used for quantified diagnoses as well as selective and specialized therapies on the basis of nonionizing electromagnetic radiation. BACKGROUND OF THE INVENTION In the current state-of-the-art, there is a variety of efforts to continue developing the nuclear magnetic resonance technology and resolving different problems related to the design, the operation and the use of nuclear magnetic resonance devices. Those efforts include the following: I) The examples listed below shall be given in terms of some particularities referring to the development of state-of-the-art devices: Such as the patent application of Jianqin Qiu and coauthors (Chinese Patent CN 1361418, published on July 31, 2002). This application intends to protect a control panel for a nuclear magnetic resonance device which operates on the basis of radio frequencies (RF) and enables direct samples of variable frequency in a complex manner. Also the patent application of Kiyoshi Matsumura and coauthors (US D457885 S, published on May 28, 2002). This application concerns a nuclear magnetic resonance tomography device. There is furthermore the patent application of Katznelson and coauthors (US 5,736,858, published on April 7, 1998). This application is about a gradient coil assembly which is used in order to obtain ultra fast images. In addition the patent application of Doty and coauthors (US 5,530,355, published on June 25, 1996). This application intends to protect a transversal gradient coil assembly which is used in order to obtain a magnetic resonance 2 image. II) Regarding the diagnoses, the following examples shall be mentioned: There is the international patent application (WO 03013616, published on February 20, 2003) of Valentino Mainero and coauthors. This application refers to the use of imaging contrast agents. The US-patent application of Christian Brevard and coauthors (US 2002121898, published on September 5, 2002) intends to protect a driving circuit which measures and recuperates the looped signal of a nuclear magnetic resonance device. The US-patent of O´Dorisio and coauthors (US 5,590,656, published on January 7, 1997) describes and intends to protect the application of radio tracers which mark diseased tissues. This method includes both the application of the radio tracers and a test for the detection of radiation. The US-patent of Haaland and coauthors (US 5,596,992, published on January 28, 1997) is about a classification of cancerous tissues with the aid of infrared radiation. The US-patent of Vo-Dinhand coauthors (US 5,579,773,) describes an apparatus and corresponding method for a Cancer diagnosis with the aid of a laser. The US-Patents US 5,420,510; US 5,404,882 and US 5,281,917 as well as the European Patent EP 0234524 describe methods for cancer diagnosis with the aid of nuclear magnetic resonance images. III) In particular regarding cancer diagnoses, there are applications in the current state-of-the-art which refer to the use of specific devices and methods that improve the diagnosis of the aforementioned disease, including: The US-patent of Ehnholm (US 6,535,755, published on March 18, 2003), which protects an apparatus and method for the increase of the signal-to-noiseratio of a nuclear magnetic resonance signal that is used for the temperature control during the treatment of the disease. The US-patent of Gray and coauthors (US 5,579,773, published on March 3 23, 1999) concerns a cancer therapy with the aid of internal radio nuclides which emit beta and gamma radiation. The US-patent of Carol (US 5,596,619, published on January 21, 1997) describes an apparatus and method for a therapy with the aid of a spatially modulated beam which penetrates a tumor. The international patent application of Svend Freytag and coauthors (WO 9620733, published on July 11, 1996) describes a Cancer therapy with the aid of selective markers which are exposed to radiation and therefore enable a combined method. The US-patent of Smith and coauthors (US 5,528,652, published on June 18, 1996) describes a brain treatment method with the aid of ionizing radiation. The international patent application of Torben Laustsen (WO 9412240, published on June 9, 1994) concerns a Cancer therapy with the aid of infrared radiation by the use of optical fibers. The European patent of Craig Nunan and coauthors (EP 0562644, published on September 29, 1993) describes an apparatus which generates irregular radiation and which is subject to a regulation of the ionizing radiation power. The US-patent of Santana-Blank (US 5,231,984, published on August 13, 1993) refers to an apparatus and a method for the application of a laser therapy on cancerous skin tissues. The European patent of Domenico Albini and coauthors (EP 0406454, published on January 9, 1991) is about an apparatus for photochemical reactions with the aid of a laser. The US-patents of Mills (US 4,815,448 and US 4,815,447, published on March 28, 1989) protect a therapy with the aid of a selective frequency radiation combined with chemotherapeutical agents. The US-patent of Stuart Mirell (US 4,690,130, published on September 1, 1987) protects an electromagnetic control system used for chemotherapies. The Japanese patent of Hioshi Endou and coauthors (JP 57185220, 4 published on November 15, 1987) describes a radiation therapy with visible light by using an agent with an active compound and chlorophyll derivative. IV) Regarding hyperthermia, which is the problematic heating of the surroundings of the radiated disease, there are applications which give attention to this problem, including: There are also the US-patents of Fenn (US 5,441,532 and US 5,251,645, published on August 15, 1995 and on October 12, 1993), which protect an element arrangement. The hyperthermia caused by radio frequencies shall be prevented with the aid of a radiation intensity control. The same is treated within the USpatents of Anderson and coauthors (US 4,819,642 and US 4,702,262, published on April 11, 1989 and on October 27, 1987). In the last mentioned patent, the hyperthermic zone is fundamentally localized. V) There are other patents which can be given as a reference, including the ones treating therapy devices: The US-patent of Rakesh Govind and Robert G. Loomis (US 5 690 109, published on November 25, 1997) concerns a therapeutic method consisting in a selective heating of the cells within a specimen, without heating the cells which are not the target of the treatment. However, due to technical limitations, the aforementioned patent was not taken into consideration by any of the manufacturers of this kind of technology. Also the patents WO 91/07132 A, EP 0695560, WO 9519841, EP 0198257, WO 8804414, EP 0252118 and WO 8703798. The Spanish patents 0240990, 0305008, 0284542, 0355750, 0340005, 0705603, 0400940, 0512981, 0650601 and 0711121. The Swiss patents CH 681356 and CH 669733 as well as the Australian patents 563137, 528476 and 534533. The Japanese patent JP 04102465 and the US-patents US 4515165, US 4524779, US 4691712, US 4935631, US 5079698, US 5168514, US 5442675, US 5464445 and US 5609816. VI) There is an immense variety of nuclear magnetic resonance devices 5 available on the market. These devices are typically used for medical diagnoses or within medical and technological research activities. These devices include e.g.: the Eclipse 1.5T of Marconi, the Symphony 1.5T of Siemens, the 1.5T Intera of Philips, the 1.5T Excite Twinspeed of General Electric, the Harmony 1.0T of Siemens, the Profile III of General Electric, the Profile II of General Electric, the Profile Platinum of General Electric, the Airis I of Hitachi, the Airis II of Hitachi, the MRP 7000 of Hitachi, the Profile III Open Mobile of General Electric, the 1.5T Echospeed Plus of General Electric, the Hispeed LX 1.5T Mobile of General Electric, the Impact Expert 1.0T Mobile of Siemens, the Horizon Mobile of General Electric, etc. All currently used devices --may they be mentioned here or not-- function in a satisfactory manner within its scope which is a mere qualitative diagnosis on the basis of images or frequency spectra. Nevertheless, there is currently no nuclear magnetic resonance device which is able to offer a quantified diagnosis or a selective and specialized therapy on the basis of a differentiated use of some of the internal parameters as power and polarity of some of the resonance frequencies of the radiation used in "conventional" diagnoses. This is precisely the objective of the nuclear magnetic resonance device proposed in the present invention: Providing a quantified diagnosis as well as a selective and specialized therapy on the basis of such a quantified diagnosis, in particular for Cancer and HIV/AIDS patients. OBJECTIVES OF THE INVENTION As is generally known, there are both devices and methods for Cancer and HIV/AIDS diagnoses and therapies in the (current state-of-the-art). In the case of cancer, scientists are facing problems regarding the reliability of diagnoses, which is due to the form of interpretation of the diagnoses resulting from the data (images) obtained from the currently available nuclear magnetic resonance devices. The devices and methods related to the Cancer diagnosis on the basis of images typically provide a mere contrasted image of the disease. This means that 6 they enable a qualitative diagnosis without illustrating anything in particular, wherefore the empirical level of the image interpretation remains unchanged. In such a way, a diagnosis with a higher grade of certainty is only achieved with respect to biopsies. In our opinion, the currently available and used possibilities of HIV/AIDS diagnosis are sufficient and reliable. In the range of cancer therapies, there are e.g.: the chemotherapy, which is used with chemical compounds like cytostatic agents and non-cytostatic agents, and the radiotherapy, which is used with ionizing radiation in almost all therapeutic applications. Regarding the use of non-ionizing radiation within therapies, it is known that its application is mostly "experimental", without having importance, neither in the medical practice, nor on the health care market. Taking into consideration the current state-of-the-art, it is necessary to eliminate the empiricism of cancer diagnoses as well as to increase the differentiation, selectivity, specialization and safety standards of Cancer and HIV/AIDS therapies in order to improve the cure of the respective patients. Therefore, the present invention includes the objective of eliminating the currently perceived empiricism of diagnoses and improving safety standards for the therapy of the aforementioned diseases by providing a nuclear magnetic resonance device which is able to offer a quantified diagnosis and a selective and specialized therapy on the basis of said quantified diagnosis as explained below. Another objective of the invention is providing a nuclear magnetic resonance device which on the one hand is able to perform a quantified diagnosis and on the other hand provides a selective and specialized therapy on the basis of the quantified diagnosis using non-ionizing electromagnetic radiation. A further objective of the invention is providing a nuclear magnetic resonance device for the performance of a selective and specialized therapy using non-ionizing electromagnetic radiation with safety standards which are unknown in the current state-of-the-art. Another objective of the present invention is providing a nuclear magnetic resonance device which --in order to comply with the aforementioned objectives-- 7 provides for a selective manipulation of the internal parameters of the radiations establishing the electromagnetic beam such as resonance frequency, power and polarity. A further objective of the present invention is providing a nuclear magnetic resonance device which provides for the suspension of the hyperthermia's harmful effects on the healthy and other tissues in the surroundings of the treated disease, may the therapy be on the basis of ionizing or non-ionizing electromagnetic radiation. Yet another objective of the invention is providing a nuclear magnetic resonance device which enables the abandonment of the use of the so called "target substances". By this means, the simultaneously occurring problems caused by a potential removal of the organism are avoided. A further objective of this invention is the suspension of the effects and consequences which cause the cellular mutability and overlap. The aforementioned behavior is characteristic for diseases like Cancer and HIV/AIDS. Yet another objective of the invention is providing a nuclear magnetic resonance device which enables the combination of the modalities of diagnosis and therapy within the same device. A further objective of the present invention is providing a nuclear magnetic resonance which provides for the prevention of collateral damages --inevitably caused by chemo and/or radiotherapies-- regarding the nervous and the immune system. Another objective of the invention is providing a nuclear magnetic resonance which enables the reduction of surgical operations as a therapeutic option. Yet another objective of the present invention is providing a selective and specialized therapy exclusively on the basis of non-ionizing electromagnetic radiation for the treatment of diseases like Cancer and HIV/AIDS. A further objective of the invention is reducing the existing time intervals between the diagnosis, the therapy and the patient's recovery by applying the nuclear magnetic resonance device together with the diagnostic and therapeutic 8 methods of the invention. Another objective of the invention is providing a diagnostic and therapeutic method directly related and specific to the nuclear magnetic resonance device of the present invention. Yet another objective of the invention is reducing the currently high costs in terms of Research & Development. These costs are associated with the search for therapeutic offers for diseases like Cancer and HIV/AIDS. A further objective of this invention is providing a device and corresponding methods for an immediate implementation on the so called health market. SHORT DESCRIPTION OF THE INVENTION Prior to providing a short description of the invention, it seems appropriate to define the meaning of "electromagnetic radiation" as used within the present application as well as to provide a differentiation between ionizing and non-ionizing radiation and how the non-ionizing radiation is used here. 1) Electromagnetic Radiation. Also called light even though it is not always visible, is a self-propagating wave in
H H H H space with electric and magnetic components. These components oscillate at
H H H H H H right angles to each other and to the direction of propagation , and are in phase
H H H H with each other. Electromagnetic radiation is classified into types according to the
H frequency of the wave: these types include, in order of increasing frequency, radio
H H H H H H H H H H H H waves , microwaves , terahertz radiation , infrared radiation , visible light , ultraviolet radiation , X-rays and gamma rays .
H H H H H EM radiation carries energy and momentum , which may be imparted when it
H H H H interacts with matter .
H H 2) Ionizing Electromagnetic Radiation. Is highly-energetic particles or waves that can detach ( ionize ) at least one electron
H H H H H H 9 from an atom or molecule . Ionizing ability is a function of the energy of individual
H H H H particles or waves, and not a function of their number. A large flood of particles or waves will not, in the most-common situations, cause ionization if the individual particles or waves are insufficiently energetic. Examples of ionizing radiation are energetic beta particles , neutrons , and alpha
H H H H H particles . The ability of light waves ( photons ) to ionize an atom or molecule varies
H H H across the electromagnetic spectrum . X-rays and gamma rays will ionize almost
H H H H H H any molecule or atom; far ultraviolet light will ionize many atoms and molecules;
H H near ultraviolet and visible light are ionizing to very few molecules; microwaves
H H H H H H H H H H and radio waves are non-ionizing radiation . Visible light is so ubiquitous that
H molecules that are ionized by it will often react nearly spontaneously unless
H protected by materials that block the visible spectrum. Examples include photographic film and some molecules involved in photosynthesis .
H H If enough ionization occurs in a biological system, they can be destructive, such as by causing DNA damage in individual cells. Extensive doses of ionizing radiation
H H have been shown to have a mutating effect on future generations arising from the
H H individual receiving the dose. Ionizing radiation has many practical uses in medicine, research, construction, and other areas. It also presents a health hazard to humans if used improperly. Both aspects are discussed below. 3) Non-ionizing Radiation. Refers to any type of electromagnetic radiation that does not carry enough energy
H H H H per quantum to ionize atoms or molecules -- that is, to completely remove an
H H H H H electron from an atom or molecule . Instead of producing charged ions when
H H H H H passing through matter, the electromagnetic radiation has sufficient energy only for excitation, the movement of an electron to a higher energy state. Nevertheless, different biological effects are observed for different types of non-ionizing radiation.
H Near ultraviolet , visible light , infrared , microwave , radio waves , low frequency RF
H H H H H H H H H and static fields are all examples of non-ionizing radiation. Visible and near 10 ultraviolet may induce photochemical reactions , ionize some molecules or
H H accelerate radical reactions , such as photochemical aging of varnishes or the
H H H H breakdown of flavoring compounds in beer to produce the ' lightstruck flavor '. The
H H light from the Sun that reaches the earth is largely composed of non-ionizing
H H radiation, with the notable exception of some ultraviolet rays. However, most
H H ionizing radiation is filtered out by the atmosphere (see Earth's atmosphere ). Static
H H fields do not radiate Albeit having a high intensity, non-ionizing radiations cannot cause ionization within a biological system. However, it has been demonstrated that these radiations generate other biological effects such as heating, interference of chemical reactions or induction of flux density within the tissues and cells. Once the definitions and differences are established, a short description of the invention will be provided. As previously mentioned, all nuclear magnetic resonance devices which are currently used for health care and research purposes are limited to diagnoses performed on the basis of qualitative images or frequency spectra. Furthermore, it is known that there is no nuclear magnetic resonance on the market enabling a quantified diagnosis and much less a specialized therapy. There is only the technological proposal of the already mentioned US-patent US 5 690 109 which gives a specific, but limited attention to the modality of therapy. Radio therapies are mostly performed applying ionizing radiation. The core manufacturers are: Siemens, Varian Medical Systems, Elekta and Tomotherapy, whereof only Siemens can be considered as an important manufacturer on both the diagnosis and therapy market. It has to be emphasized that the currently available systems on the market neither use non-ionizing radiation for therapies, nor possess the necessary technology to perform a selective manipulation of the internal parameters of 11 electromagnetic radiation emitted by the device in the modality of diagnosis, so that the non-ionizing radiation can be selectively, specifically and safely provided according to the therapeutic interests. In accordance with the aforementioned aspects, the present invention reveals a modified conventional nuclear magnetic resonance device which includes additional hardware components that enable a quantified diagnosis in addition to the "conventional" qualitative diagnosis. Additionally, a modified conventional nuclear magnetic resonance device is disclosed which has been subject to necessary changes in regard to some of its default parts including new hardware that enables the device not only to provide a qualitative "conventional" diagnosis, quantified diagnosis, but also a selective and specialized therapy on the basis of non-ionizing radiation which is regulated through the selective manipulation of the respective internal parameters of the radiation such as: Resonance frequency, power and polarity. Another aspect of the invention is the provision of two methods: a quantified diagnosis and a subsequently performed selective and specialized (and not standardized) therapy on the basis of non-ionizing radiation. This radiation is programmed and adjusted in terms of the particular values of the internal parameters such as resonance frequency, power and polarity inherent in the pathology and according to the therapeutic interests. In accordance with the aforementioned aspects of the invention and in order to achieve the said objectives, the nuclear magnetic resonance device of the invention comprises basic components and parts (hardware) which are described as follows. It shall be understood that experts of this area will agree that there may be modifications and changes without reducing the scope of the invention. Therefore, the subject matter of the present invention is only limited by the accompanying patent claims. The components (hardware) of the nuclear magnetic resonance device of the invention, which includes the aspects of a quantified diagnosis and a selective and specialized therapy, are the following (as shown in figure 11): 12 (I) Conventional Nuclear Magnetic Resonance Device. A conventional nuclear magnetic resonance device consists generally of the following components and parts (hardware), as shown in figure 11: (1) Magnet with integrated Cooling System and Insulation for the Assembly. (2) (3) (4) (5) (6) (7) (8) (9) Shim Coil System. Gradient System Coils. Radiofrequency Resonance Antennas Patient Couch. Transmit-Receive-Selector. Preamplifier. Magnet and Radio Frequency Protection Walls. Low Frequency Signal Processor/Quadrature Demodulator with LowPass Filter. (10) (11) (12) (13) (14) Low Frequency Signal Processor/Modulator. Analog-to-Digital-Converter (ADC). Digital-to-Analog-Converter (DAC). Radio Frequency Pulse Amplifier. Gradient Amplifiers X, Y, Z with their respective Digital-to-AnalogConverters. (15) (16) (17) (19) (20) (21) (22) (23) (24) Magnet Power Supply Unit. Central Pulse Control. Frequency Processor. Image Processor. Central Computer. Image Storage. Operator's Console. Protocol Monitor. Monitor for Conventional Images. 13 (27) Keyboard. (II) The components and parts to be added in order to provide a quantified diagnosis. In order to enable a conventional nuclear magnetic resonance device to perform a quantified diagnosis, the present invention proposes to add the following components and parts (new hardware), as shown in figure 11: (18) (25) (26) (28) Controlled Digital Filter/Selector. Frequency Matrix Monitor. Frequency Images Monitor. Control Panel. As can be seen in figure 11, the new components and parts (new hardware) affect the respective components and parts which belong to the (17) Frequency Processor and the (23) Protocol Monitor of the nuclear magnetic resonance. (III) Components and parts to be modified for the therapy on the basis of non-ionizing radiation. In order to enable the conventional nuclear magnetic resonance to perform a selective and specialized therapy on the basis of non-ionizing radiation (modified hardware), the present invention proposes the modification of the following components and parts, which are shown in figure 11: (4) (10) (13) (16) (22) Radiofrequency Resonance Antennas Low Frequency Signal Processor/Modulator. Radio Frequency Pulse Amplifier. Central Pulse Control. Operator's Console (it is modified incorporating the Frequency Matrix Monitor and the Frequency Images Monitor as well as the Controlled 14 Digital Filter/Selector). In order to obtain diagnostic images, the physical principle of nuclear magnetic resonances is of importance. Images are obtained upon processing the radio frequency signals emitted by the treated area, which has been previously excited by the radio frequency signals emitted by the Radiofrequency Resonance Antennas (4). Under the effect of the magnetic field generated by the Magnet (1), the treated area emits an energy which is captured by the Radiofrequency Resonance Antennas (4) and the respective data is entered in the Frequency Processor (17), where it is converted from analog to digital with the aid of the Analog-to-Digital-Converter (ADC) (11). Afterwards, the Frequency Processor (17) internally processes only the radio frequency signals from the treated area in its return to the state of equilibrium. These signals, while mathematically processed through the Fourier transform, help to obtain the known conventional images, which can be observed with the aid of the Monitor for Conventional Images (24). With the aid of the components and parts to be modified, it is possible to exactly specify the resonance frequency values of the different areas treated. In this regard, the Controlled Digital Filter/Selector (18) is used. With the aid of the components and parts to be added (new hardware), it is possible to display said resonance frequencies in text format on the Frequency Matrix Monitor (25) and in a graphical format or in form of images on the Frequency Images Monitor (26). By this means, it is possible to obtain a resonance frequency profile of the examined area and consequently the quantification of the diagnosis. All the aforementioned aspects are in addition to the qualitative data which provides the Monitor for Conventional Images (24), which is already available in conventional nuclear magnetic resonance devices. This means that with the present invention it is possible to dispose of both ways to obtain visual data at the same time. 15 A nuclear magnetic resonance device is used in the present invention in order to obtain a diagnosis on the basis of the quantification of the resonance frequency values at which the treated area resonates. By this means, it is clearly detected where energy transfers and at which resonance frequency values they occur, provided that according to the needs it will be necessary to apply or extract heat to or from the treated area. The described extraction of heat from the treated area is absolutely unknown in the current state-of-the-art. As for the therapy, the present invention uses a modified nuclear magnetic resonance device in order to program and emit the non-ionizing radiation through the radio frequency emitting antennas. For the implementation of this modality, it is necessary to modify the conventional nuclear magnetic resonance device as described before. By this means, it is possible to modify the power and polarity values of the selected resonance frequencies in order to selectively and specifically achieve determined objectives within the therapeutic area. Therefore, the previously --during the quantified diagnosis-- obtained resonance frequencies are used, and the power and polarity of the resonance frequency signals are adjusted in order to apply the respective non-ionizing electromagnetic radiation in a selective, specialized and differentiated manner. The present invention proposes the use of the same nuclear magnetic resonance device for both the diagnosis and the therapy. It is very important to point out that applying exclusively non-ionizing electromagnetic radiation for the modality of therapy, on the basis of the quantified diagnosis of this invention, the calculations in regard of the dosimetry of the radiation to be applied in the therapy not only are simplified and exact, but also provide for safety standards and introducing high standards of security to the therapeutic application, unknown in the current state-of-the-art. In addition, the present invention provides two methods which enable the flawless operation of the nuclear magnetic resonance device, so that a quantified diagnosis and a selective and specialized therapy on the basis of non-ionizing radiation can 16 be performed. The aforementioned aspects which are related to the hardware are supported by another aspect which includes the respective methods for the implementation of the quantified diagnosis and the selective and specialized therapy. In addition, the present invention provides for a quantified diagnosis on the basis of a modified nuclear magnetic resonance device. By this means, the following is proposed: A method of a quantified diagnosis of a diseased area, using a modified nuclear magnetic resonance device. The following hardware is added to this device: a Controlled Digital Filter/Selector (18), a Frequency Matrix Monitor (25), a Frequency Image Monitor (26) and a Control Panel (28). The aforementioned method is also characterized by the following steps: - Provision of a diseased area for the nuclear magnetic resonance device of the invention; - Application of the traditional nuclear magnetic resonance technology in order to obtain a qualitative diagnosis of the area (an image of the diseased area); - Interconnecting the Frequency Processor (17) to obtain the signal generated by the diseased area in its return to the state of equilibrium; - Manipulation of the Manually Controlled Digital Filter/Selector (18) of the Control Panel (28) located at the Operator's Console (22) of the nuclear magnetic resonance device in order to exactly specify the useful resonance frequency values (FRUT) and its respective power and polarity values; - Obtainance of the specific resonance frequency values from different zones within the diseased area with the aid of the Frequency Matrix Monitor (25); - Obtainance of the graphical profile (qualitative) of the exact location of the resonance frequencies within the diseased area with the aid of the Frequency Images Monitor (26); - Obtainance of the qualitative data which is basically related to the density of the tissues of the diseased area with the aid of the Monitor for Conventional Images (24); and 17 - Input of the obtained data in order to provide a qualitative and quantified diagnosis of the diseased area, with the objective to implement a selective and specialized therapy. Finally, the present invention provides also a method for a selective and specialized therapy on the basis of non-ionizing electromagnetic radiation applied through the modified nuclear magnetic resonance device of the invention. By this means, the following is proposed: A method to provide a selective and specialized therapy on the basis of a quantified diagnosis of the treated area, using a nuclear magnetic resonance device where the following hardware is modified: Radiofrequency Resonance Antennas (4), the Low Frequency Signal Processor/Modulator (10), the Radio Frequency Pulse Amplifier (13), the Central Pulse Control (16), and the Operator's Console (22), said method for the provision of a selective and specialized therapy, being also characterized by the following steps: - Provision of a modified nuclear magnetic resonance device, - Input of the previously obtained values of the selected parameters resonance frequency, power and polarity in the Central Computer (20); - Enabling the Central Computer (20), the Central Pulse Control (16), the Digital-to-Analog-Converters (12), the Low Frequency Signal Processor/Modulator (10), the Radio Frequency Pulse Amplifier (13) and the Radiofrequency Resonance Antennas (4) to operate the parameters previously selected and differently manipulated [Useful Resonance Frequency values (FRUT) and their respective Power and Polarity values), parameters which are entered in the Central Computer (20) exclusively to provide the modality of therapy; - Performance, with the aid of the modified nuclear magnetic resonance device, of a non-ionizing electromagnetic radiation emission in order to provide a selective and specialized therapy, where the Monitor for Conventional Images (24), the Frequency Matrix Monitor (25) and the Frequency Images Monitor (26) cooperate in order to display the evolution of the treated area in real time. 18 SHORT DESCRIPTION OF THE FIGURES The description of the structure and the functioning of the invention regarding the quantified diagnosis and the selective and specialized therapy is more comprehensive with the aid of the attached figures, where: Figure 1 shows the effect of the currently used ionizing radiation which penetrates a biological medium including the affected area. Figures 2a and 2b demonstrate the two possible interactions which may produce non-ionizing radiation --without the use of a target substance-- within a biological medium. Figure 3 shows the interaction between the non-ionizing radiation and the particles of the target substance within a biological medium. Figure 4 illustrates the diseased tissue within an ionizing or non-ionizing therapy. Figure 5 demonstrates the tumor tissue which is selectively irradiated by non-ionizing radiation. Figure 6 shows the effect of a non-ionizing radiation beam which incides in the hyperthermic area located in the surroundings of the healthy tissue. Figure 7 illustrates the effect of a non-ionizing radiation beam which incides in a healthy perimetric area that is not affected by hyperthermia. Figure 8 shows the visual integration of the figures 5, 6 and 7, with the objective to clarify the concept "sequence of the emission pattern". Figure 9 illustrates the graphs which represent the signals of three different radiation beams applied according to the basic principle of the magnetic resonance device - for the use of the Complex Therapy R-3 - considering the respective parameters of the resonance frequency: power and polarity. The fourth line demonstrates the signal which represents a combined effect that occurs upon the application of the three radiation beams. Figure 10 shows a "conventional" radio frequency emission penetrating a biological medium. Figure 11 illustrates a schema of the underlying nuclear magnetic 19 resonance device (Zero-Series Prototype VPEPN/H-201), which includes the necessary components (New Hardware) of a conventional device in order to enable a qualitative and quantified diagnosis as well as the modified components (Modified Hardware) in order to provide a selective and specialized therapy. DETAILED DESCRIPTION OF THE INVENTION The invention is now described in detail with the aid of the attached figures. Within the following description, similar components are specified and the drawings contain the same reference numbers. The drawings of the figures are not to scale and certain components are shown in a simplified manner for the sake of clarity. Figure 1, illustrating the effect of ionizing radiation applied according to the current state-of-the-art, shows the area of influence of the route (4A) of the radiation (R) within a biological medium (2A). This radiation ionizes (6A) the entire biological medium (2A). Due to hyperthermia, it generates also harmful side effects in the perimetric area (3A) in the surroundings of the pathology (P). The inciding ionizing radiation beam of the currently used technology generates harmful side effects of different extent during both the diagnosis and even more the therapy. Regarding figures 2a and 2b, which refer to the use of non-ionizing radiations without applying a target substance, the two possible interactions within a biological medium can be perceived: Figure 2a shows a biological medium without hyperthermia, provided that the radiation (R) does not provoke resonance neither in the underlying pathology (P) nor in the medium (2A). Figure (2b) illustrates the perimetric area (3A) with hyperthermia within the medium which is penetrated (2A), provided that there is a resonance in pathology (P) as a result of the radiation (R). Figure 3, which refers to the use of non-ionizing radiations by applying a target substance, shows the hyperthermic area (3A) around the diseased tissue (P). The hyperthermic area is a result of the heating provoked by the interaction (resonance) of the radiation (R) with the particles of the target substance (7A) in the surroundings of the tumor tissue (P). In addition to the harmful side effects on 20 the healthy tissue (2A) provoked by hyperthermia, there is the difficulty of removal of the target substance (7A) from the organism. Figure 4, which refers to the tumor areas, illustrates the diseased areas which are subject to a therapy on the basis of ionizing or non-ionizing radiation. There is a tumor tissue (P) where the area (2A) represents a healthy tissue which is partially affected by the hyperthermia shown within the dotted circle (3A). Reference (4A) demonstrates the route of the incident radiation in the tissue and reference (5A) represents the potential removal of the target substance (7A), provided its use. Figure 5, which refers to the tumor tissue, shows the tumor area (P) being selectively irradiated by the non-ionizing radiation (R), which provokes a resonance in the pathology (P) at the previously established resonance frequency (f 1). By this means, the pathology (P) absorbs the quantity of energy in form of heat that enables its destruction, providing at the same time for the release of the excessive heat (8A) towards the healthy medium (2A). The radiation (R) which provokes resonance in the diseased tissue (P) incides with the resonance frequency (f 1) that is specific for said tissue, with a determined power (P 1) and polarity (Pol 1). Within the present invention, such resonance frequency is exactly identified and quantified during the quantified diagnosis. Afterwards the necessary hardware of the nuclear magnetic resonance device is enabled to permit the selection of the useful resonance frequencies (FRUT) and the selective modification of their power and polarity, according to the therapeutic interests. By this means, it is possible to eliminate the diseased tissue (P) in a differentiated, selective and specialized manner. Figure 6, which refers to the perimetric area of the healthy tissue with hyperthermia, shows the non-ionizing radiation beam (R) that possesses a resonance frequency (f 3) and respective power (P3) and polarity (Pol 3), inciding in the hyperthermic area (3A) located in the area of healthy tissue (2A) which is affected by such a thermal dissipation. This tissue absorbs the heating excess emitted by the tumor tissue (P) which is being destroyed by the heating. In this 21 case, a negative polarity of the incident radiation is considered as an indicator of the energy absorption. During the quantified diagnosis, the resonance frequency (f3) was previously identified on the basis of the proposed method in order to apply the selective and specialized therapy. The selective modification of the frequency power and polarity will be performed according to the different therapeutic interests. Figure 7, which refers to the perimetric area of the healthy tissue, demonstrates the pathology (P) and the healthy perimetric area (2A) that is not affected by hyperthermia (3A). Both are penetrated by the non-ionizing electromagnetic radiation (R) with the resonance frequency (f 2) and its respective values of power (P2) and polarity (Pol 2). This radiation will contribute or extract energy to or from said healthy perimetric area (2), according to the therapeutic interests and the bioenergetic balance. Figure 8 shows the visual integration of the figures 5, 6 and 7, with the objective to clarify the concept sequence of the emission pattern. In this specific case, R1 is the radiation which acts on the healthy tissue (2A), R 2 is the radiation which interferes against the pathology (P) and R 3 is the radiation which absorbs the hyperthermia (3A). The Complex Therapy R-3 operates on the basis of three different resonance frequencies which are included in the graph of the pulse sequence (R), as shown in the lower part of figure 8, in order to provide a more comprehensive explanation of the basic concept of the present invention. The sequence and form of the emission pattern of the non-ionizing electromagnetic radiation provides the most elevated tolerable harmful effect towards the diseased tissue (P) and that there are no chances of survival for the malignant cells which form the tissue. It also provides for an adequate solution of the hyperthermia problem and the avoidance of all harmful side effects for the healthy tissue (2A) in the surroundings of the diseased tissue (P) to be treated as well as for the nervous and immune system. Figure 8 shows the visual integration of the emission beams of the figures 5, 6 and 7. These beams form a single emission sequence (R). The behavior or ratio of the values of the parameters 22 frequency (f), power (P) and polarity (Pol) is as follows: f1 f2 = f3 P1> P2 = P3 Polarity (Pol), where: Pol1 is positive (+) Pol2 is positive (+) or negative (-) Pol3 is negative (-) Figure 9 illustrates the graphs of the basic functional principle of the underlying device used for the Complex Therapy R-3, where R 1 is the radiation which acts on the healthy tissue (2A) with an alternating emission sequence, R 2 is the radiation which interferes against the pathology (P) with a continuous and positive emission sequence, and R 3 is the radiation which absorbs the hyperthermia (3A) with a continuous and negative emission sequence. The ratio of the values of the variables frequency (f), power (P) and polarity (Pol) would be: f1 f 2 = f3 P1 > P2 = P3 Polarity (Pol), where: Pol1 is positive (+) Pol2 could be positive (+) or negative (­) Pol3 is negative (­) Figure 10, which refers to the "conventional" emission, shows a radio frequency emission composed of the radiations R 1, R2 and R3 which penetrate a biological medium (2A). Figure 10 also demonstrates the respective parameters of the resonance frequency, power and polarity. The radiations R1, R2 y R3 form an indivisible beam and in this example the ratio between the parameters is: f1 f 2 f 3 P1 = P2 = P3 Pol1 = Pol2 = Pol3 (with equal signs) 23 Figure 11 shows the functional schema of the parts composing the nuclear magnetic resonance device of the present invention. This device has been materialized in the form of the Zero Series Prototype VPEPN/H-201, and is proposed to be used for the qualitative and quantified diagnosis as well as for the selective and specialized therapy. The basic components and parts (hardware) of the Zero Series Prototype VPEPN/H-201 would be the following: (1) Magnet with integrated Cooling System and Insulation for the Assembly. (2) (3) (4) (5) (6) (7) (8) (9) Shim Coil System. Gradient System Coils. Radiofrequency Resonance Antennas. Patient Couch. Transmit-Receive-Selector. Preamplifier. Magnet and Radio Frequency Protection Walls. Low Frequency Signal Processor/Quadrature Demodulator with LowPass Filter. (10) (11) (12) (13) (14) Low Frequency Signal Processor/Modulator. Analog-to-Digital-Converter (ADC). Digital-to-Analog-Converter (DAC). Radio Frequency Pulse Amplifier. Gradient Amplifiers X, Y, Z with their respective Digital-to-AnalogConverters. (15) (16) (17) (18) (19) (20) Magnet Power Supply Unit. Central Pulse Control. Frequency Processor. Controlled Digital Filter/Selector. Image Processor. Central Computer. 24 (21) (22) (23) (24) (25) (26) (27) (28) Image Storage. Operator's Console. Protocol Monitor. Monitor for Conventional Images. Frequency Matrix Monitor. Frequency Images Monitor. Keyboard. Control Panel. The components and parts to be added to the currently used nuclear magnetic resonance devices in order to provide a quantified diagnosis are as follows: (18) (25) (26) (28) Controlled Digital Filter/Selector. Frequency Matrix Monitor. Frequency Images Monitor. Control Panel. The components and parts to be modified in order to enable the currently used nuclear magnetic resonance devices to provide a selective and specialized therapy on the basis of non-ionizing radiation are as follows: (4) Radiofrequency Resonance Antennas [they are modified so that they can process the respective Power and Polarity values of the Useful Resonance Frequencies (FRUT), in a range of variable and different values, to the established in the design parameters of the modality of qualitative "conventional" Diagnosis] (10) Low Frequency Signal Processor/Modulator [it is modified to allow increasing the bandwidth and frequency respond (Pulse Form)]. (13) Radio Frequency Pulse Amplifier (it is modified to allow increasing 25 the bandwidth and emission power). (16) Central Pulse Control [it is modified to allow carrying out reprogrammings and be functional not only to work with the fixed parameters (preestablished in the design)] (22) Operator's Console [it is modified incorporating the Frequency Matrix Monitor (25) and the Frequency Images Monitor (26) as well as the Manually Controlled Digital Filter/Selector (18)]). The nuclear magnetic resonance device of the present invention is illustrated and described by the Zero Series Prototype VPEPN/H-201 of figure 11. The device permits a selective manipulation of the internal parameters of the radiations which form the electromagnetic emission such as resonance frequency, power and polarity of the radiation. With the aid of the device, the values of the parameters are obtained during the performance of the quantified diagnosis and used during the selective and specialized therapy. The respective radiations will incide in the previously identified area of interest. Being able to quantify the resonance frequencies of different cellular compounds, the device enables a quantified diagnosis. By this means, the modality of diagnosis is significantly improved and the application of a selective and specialized therapy can be provided which is unknown in the current state-of-the-art. The procedure begins, in accordance with the method of the quantified diagnosis of the present invention, using the traditional nuclear magnetic resonance technology, where a radio frequency beam is sent to the area to be treated in order to excite its hydrogen atoms. Upon ceasing the emission, the hydrogen atoms of the treated area return to their state of equilibrium and generate an energy which is captured by the Radiofrequency Resonance Antennas (4) and stored and processed by the Frequency Processor (17). Upon detecting the respective signals, an image of the area affected by the pathology is obtained, which is consistent with the already known qualitative "conventional" diagnosis. The data which is provided by the signals obtained through the Manually 26 Controlled Digital Filter/Selector (18), the Frequency Matrix Monitor (25), the Frequency Images Monitor (26) and the Control Panel (28) (additional hardware) enables to know and observe the electromagnetic profile of the resonance frequencies of the area of interest. This diagnostic data is indispensable for both the quantification of the diagnosis and the programming of the selective and specialized therapy. This therapy is performed on the basis of the data obtained with the aid of the new or modified components and parts (hardware) of the nuclear magnetic resonance. This procedure significantly improves the modalities of diagnosis and therapy of the current medical practice, since conventional images are still obtained using this technology. During the diagnosis and in accordance with the underlying method of the quantified diagnosis, the Frequency Matrix Monitor (25) shows the data of the resonance frequencies in text format, the Frequency Images Monitor (26) illustrates images depending on the inherent resonance frequencies of every treated tissue, organ and system, and the Monitor for Conventional Images (24) displays images considering the behavior of the density in the treated area. With the aid of the aforementioned monitors and functions, a graphical data of the resonance frequencies is obtained. Thus, the exact electromagnetic profile of such resonance frequencies, which correspond to the very specific areas within the treated tissue, can be achieved. Through the Control Panel (28), which is located at the Operator's Console (22), it is possible to manipulate the Manually Controlled Digital Filter/Selector (18) used for the exploration and analysis that depend on the therapeutic requirements of the tre